Clinuvel Pharmaceuticals (CLVLY) News Today $9.05 +0.17 (+1.91%) (As of 11/19/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPPSeptember 30, 2024 | globenewswire.comClinuvel Pharmaceuticals goes ex dividend MondaySeptember 7, 2024 | msn.comClinuvel Pharmaceuticals Limited (CLVLF) Gets a Buy from MorgansAugust 30, 2024 | markets.businessinsider.comASX Health Stocks: Clinuvel, MedAdvisor rally after hitting high notes on profitsAugust 29, 2024 | msn.comAfamelanotide in fair-skinned Parkinson's patientsJune 17, 2024 | globenewswire.comPhotomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German InvestorsMarch 28, 2024 | globenewswire.comClinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years agoMarch 21, 2024 | finance.yahoo.comClinuvel Pharmaceuticals Ltd ADR (CLVLY)March 20, 2024 | investing.comThe Clinuvel Pharmaceuticals share price is up 236% in 12 monthsMarch 9, 2024 | fool.com.auMalibu shines a light on CLINUVEL's pioneering work in photomedicineMarch 4, 2024 | globenewswire.comClinuvel Pharmaceuticals Ltd. ADRMarch 2, 2024 | wsj.comClinuvel Pharmaceuticals (CLVLF) Price Target Increased by 5.58% to 19.75February 25, 2024 | msn.comClinuvel Pharmaceuticals GAAP EPS of A$0.22, revenue of A$32.25BFebruary 23, 2024 | msn.comClinuvel Pharmaceuticals Ltd.January 30, 2024 | wsj.comClinuvel Pharmaceuticals Ltd ADRDecember 9, 2023 | morningstar.comClinuvel Pharmaceuticals Ltd ADR CLVLYDecember 2, 2023 | morningstar.comClinuvel Pharmaceuticals Ltd - ADR (CLVLY) Price Target Increased by 18.27% to 21.08October 31, 2023 | nasdaq.comClinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 38% loss from investing in the stock three years agoOctober 5, 2023 | finance.yahoo.comClinuvel Pharmaceuticals (CLVLF) Price Target Increased by 12.19% to 18.70September 1, 2023 | msn.comCould The Market Be Wrong About Clinuvel Pharmaceuticals Limited (ASX:CUV) Given Its Attractive Financial Prospects?May 3, 2023 | finance.yahoo.comSome Patients With a Rare Disease Face Hurdles Getting the Only TreatmentMay 1, 2023 | msn.comClinuvel Pharmaceuticals (ASX:CUV) shareholders have earned a 14% CAGR over the last five yearsMarch 30, 2023 | finance.yahoo.comAnalysts Just Slashed Their Clinuvel Pharmaceuticals Limited (ASX:CUV) EPS NumbersMarch 1, 2023 | finance.yahoo.comCLINUVEL Launches CYACÊLLE, Next Generation Solar CareMarch 1, 2023 | finance.yahoo.comWhy Clinuvel, Cogstate, Omni Bridgeway, and Westgold shares are sinkingFebruary 25, 2023 | msn.comClinuvel Pharmaceuticals First Half 2023 Earnings: EPS: AU$0.23 (vs AU$0.12 in 1H 2022)February 24, 2023 | finance.yahoo.comClinuvel Pharmaceuticals Limited: Global SCENESSE demand drives increased CLINUVEL revenues, earningsFebruary 24, 2023 | finanznachrichten.deGlobal SCENESSE® demand drives increased CLINUVEL revenues, earningsFebruary 23, 2023 | finance.yahoo.comClinuvel Pharmaceuticals Limited: CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned IndividualsFebruary 2, 2023 | finanznachrichten.deCLINUVEL Trial Results Show Drug Reduces DNA DamageJanuary 15, 2023 | finance.yahoo.comClinuvel Pharmaceuticals' (ASX:CUV) earnings growth rate lags the 25% CAGR delivered to shareholdersSeptember 19, 2022 | finance.yahoo.comCLVLY Clinuvel Pharmaceuticals LimitedJune 17, 2022 | seekingalpha.comDo Insiders Own Lots Of Shares In Clinuvel Pharmaceuticals Limited (ASX:CUV)?May 16, 2022 | finance.yahoo.comCLINUVEL progresses vitiligo treatment programMay 10, 2022 | finance.yahoo.comLetter to shareholders from CLINUVEL's CEOApril 29, 2022 | stockhouse.comLetter to shareholders from CLINUVEL’s CEOApril 29, 2022 | finance.yahoo.comClinuvel Pharmaceuticals' (ASX:CUV) investors will be pleased with their solid 139% return over the last five yearsApril 12, 2022 | finance.yahoo.comClinuvel Pharmaceuticals reports 1H resultsFebruary 23, 2022 | seekingalpha.comWhat Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?December 3, 2021 | finance.yahoo.comClinuvel Pharmaceuticals Limited (CLVLY)September 3, 2021 | au.finance.yahoo.com Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket. Click here and I’ll tell you everything you need to know. CLVLY Media Mentions By Week CLVLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLVLY News Sentiment▼1.000.35▲Average Medical News Sentiment CLVLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLVLY Articles This Week▼00▲CLVLY Articles Average Week Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News BCTXW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CLVLY) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinuvel Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Clinuvel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLVLY Stock Alerts